Results 151 to 160 of about 14,940 (200)

Cefoperazone-Sulbactam and Risk of Coagulation Disorders or Bleeding: A Retrospective Cohort Study

open access: yesExpert Opinion on Drug Safety, 2020
Objectives: Limited evidence has suggested that cefoperazone-sulbactam causes coagulation disorders and bleeding. Methods: The authors conducted a retrospective study to compare patients receiving cefoperazone-sulbactam versus those treated with ...
Yu Wu, Jing Tan, Xin Sun
exaly   +2 more sources

Cefoperazone and Prothrombin Time

Annals of Internal Medicine, 1987
Excerpt To the editor: In their article on the relationship between beta-lactam antibiotics and coagulopathy, Sattler and colleagues (1) cited our results (2) from a multicenter trial of cefoperazo...
M S, Cohen, H E, Washton
openaire   +2 more sources

Comparative in vitro activity of cefoperazone and various combinations of cefoperazone/sulbactam

Diagnostic Microbiology and Infectious Disease, 1990
Cefoperazone with 2 and 4 micrograms/ml of sulbactam and in a 2:1 ratio was tested against 1258 clinical isolates of Gram-positive and Gram-negative bacteria, as well as against Gram-negative bacilli that had stably derepressed Type I beta-lactamase or that were hyperproductive of non-Type I beta-lactamases.
C C, Knapp   +2 more
openaire   +2 more sources

[Kinetics of cefoperazone and cefoperazone and cephalothin in rat tissues].

Schweizerische medizinische Wochenschrift, 1980
In order to study the behavior of two cephalosporines in various tissues, 100 mg/kg of cefoperazone (CPZ) or cefalotine (CLT) were administered intraperitoneally to Wistar rats. The animals were sacrificed by groups of 6 at intervals ranging from 30 min to 6 hours after the injection and bioassay of the antibiotic was carried out in 9 organs, the serum,
J, Fabre   +3 more
openaire   +1 more source

Home - About - Disclaimer - Privacy